Transcatheter Cardiovascular Therapeutics (TCT)

The Transcatheter Cardiovascular Therapeutics (TCT) conference is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and the largest conference focused on interventional cardiovascular medicine. TCT includes seminars on all areas of intervention cardiology, structural heart, vascular in interventions, peripheral artery disease, and other procedures in the cath lab.

Cardiologist shares his long journey from Libya to United States
Abdel Almanfi, MD, went through years of training in Libya, but then he had to start over once he landed in the United States.
Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB
When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing.
Why financial literacy is so important for structural heart program directors
Carrie Redick, an ICU nurse for nearly 20 years, said understanding more about financial data improved her ability to acquire funding and other resources for her program when necessary.
Data registries have been a huge success for U.S. structural heart programs
ACC/STS National Cardiovascular Data Registry metrics reporting for TAVR is important for marketing and care quality, explains Patricia Keegan, NP, with the Emory Heart and Vascular Center.
CroíValve kicks off early feasibility study for new TR device, names cardiologist Martin Leon to advisory board
The company hopes to enroll 15 patients to monitor the safety and effectiveness of its new-look transcatheter device for severe tricuspid regurgitation.

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research.

Cardiologist Valentin Fuster named president of Mount Sinai Heart

The hugely influential doctor will still serve as the general director of the Spanish National Center for Cardiovascular Research and editor-in-chief of the Journal of the American College of Cardiology.

October 18, 2022

VIDEO: Role of PFO closure in stroke prevention

John Carroll, MD, director of interventional cardiology and professor of medicine at the University of Colorado, explains the state of transcatheter closure of patent foramen ovale (PFO) to prevent stroke.

October 10, 2022

Leadership. Healthcare CEO turnover surged in the final months of 2022, indicating that the disruptive labor challenges that have defined this year may not be over.

Industry insights: 4 healthcare executives discuss the biggest challenges in cardiology today

We spoke to executives from some of healthcare's most prominent vendors to find out what challenges are on their radar in 2022 and beyond.

October 4, 2022

High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Impella heart pumps boost survival up to 81% for cardiogenic shock patients

The heart pumps appear to provide significant benefits for patients with acute myocardial infarction- or myocarditis-related cardiogenic shock.

September 28, 2022

The Medtronic Intrepid transcatheter mitral valve replacement (TMVR) system performed well in two studies presendted at TCT 2022. #TCT #TCT22 #TCT2022 #TMVR

Intrepid transcatheter mitral valve pilot study shows positive 3-year outcomes

New data on the Medtronic Intrepid transcatheter mitral valve replacement system from the Intrepid Pilot Study and Intermediate-Term Outcomes of the Intrepid Early Feasibility Study, were presented at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference.

September 26, 2022

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD trial prsented at SCAI 2022. #DisruptPAD, #DisruptCAD, #SCAI #SCAI22 #SCAI2022

Is IVL equally effective in male and female patients? Shockwave Medical aims to find out with a historic new study

Shockwave announced at TCT 2022 that it hopes to enroll up to 400 patients for a new all-female clinical trial.

September 22, 2022

The Pulnovo pulmonary artery denervation catheter. In February 2021, the devices was granted the U.S. Food and Drug Administration (FDA) breakthrough device designation. #TCT2022 #PAH

Pulmonary artery denervation shows promise to treat pulmonary arterial hypertension

Pulmonary artery denervation may offer a new therapy option for this difficult-to-treat population.

September 21, 2022

The Pascal transcatheter mitral valve repair system. Similar to the latest version of the MitraClip, the Pascal can operate each leaflet independently to grasp the mitral valve leaflets. Results of the CLASP IID trial at #TCT2022.

Pascal transcatheter mitral repair device performs as well as MitraClip in late-breaking CLASP IID Trial

Comparison between transcatheter edge-to-edge repair (TEER) devices found Pascal was non-inferior compared with MitraClip in the CLASP IID pivotal trial.

September 20, 2022

Transcatheter Cardiovascular Therapeutics (TCT)

Cardiologist shares his long journey from Libya to United States

Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB

Why financial literacy is so important for structural heart program directors

Data registries have been a huge success for U.S. structural heart programs

CroíValve kicks off early feasibility study for new TR device, names cardiologist Martin Leon to advisory board